DAVITA INC. is 6.3x more valuable than Progyny, Inc. by market capitalization ($12.75 B vs $2.02 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PGNY | DVA |
|---|---|---|
| Market cap | $2.02 B | $12.75 B |
| US-listed rank | #2093 | #812 |
| Revenue (latest FY) | $1.29B | $13.64B |
| Net income (latest FY) | $58.52M | $1.08B |
| Net margin | 4.5% | 7.9% |
| P/E (trailing FY) | 34.5 | 11.8 |
| SEC filings | 893 | 3,248 |
DAVITA INC. is 6.3x more valuable than Progyny, Inc. by market capitalization ($12.75 B vs $2.02 B).
In their latest fiscal years, Progyny, Inc. reported $1.29B in revenue while DAVITA INC. reported $13.64B.
Full pages: Progyny, Inc. and DAVITA INC., or browse the full rankings.